MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

Jupiter Wellness Inc

Healthcare US JUPW

NoneUSD
-(-%)

Last update at 2024-01-23T20:00:34.759130Z

Day Range

--
LowHigh

52 Week Range

0.307.50
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap49.33M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-10.92478M
  • Revenue TTM5.96M
  • Revenue Per Share TTM0.25
  • Gross Profit TTM 0.54M
  • Diluted EPS TTM-0.63

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -15.22303M -28.10025M -6.28920M -0.92546M -
Minority interest - - - - -
Net income -17.67148M -29.83635M -6.40601M -0.93202M -
Selling general administrative 12.52M 17.31M 5.58M 0.91M -
Selling and marketing expenses - - - - -
Gross profit 1.03M 0.54M 0.44M -0.01157M -
Reconciled depreciation 0.52M 0.19M 0.16M - -
Ebit -11.48820M -16.76384M -5.13209M -0.92546M -0.35840M
Ebitda -10.96740M -16.57593M -4.97071M -0.91890M -
Depreciation and amortization 0.52M 0.19M 0.16M - -
Non operating income net other - - - - -
Operating income -11.48820M -16.76384M -5.13209M -0.91890M -
Other operating expenses 17.69M 19.65M 6.20M 0.93M 0.07M
Interest expense 1.29M 1.74M 0.12M 0.00656M 0.00000M
Tax provision - - - - -
Interest income 0.00172M 0.00732M 0.00304M 0.00138M -
Net interest income -1.28465M -1.72878M -0.11377M -0.00518M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.45M 1.74M 0.12M 0.00656M -
Total revenue 6.20M 2.88M 1.07M 0.00645M -
Total operating expenses 12.52M 17.31M 5.58M 0.91M -
Cost of revenue 5.17M 2.34M 0.62M 0.02M -
Total other income expense net -3.73482M -11.33640M -1.15712M -0.00656M -
Discontinued operations - - - - -
Net income from continuing ops -15.22303M -28.10025M -6.28920M -0.92546M -
Net income applicable to common shares - -28.10025M -6.28920M -0.92546M -0.35840M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 8.69M 18.87M 6.53M 0.75M 0.19M
Intangible assets 0.29M 0.74M 0.56M - -
Earning assets - - - - -
Other current assets 4.38M 0.62M 0.15M 0.05M -
Total liab 5.03M 2.27M 2.13M 0.37M 0.00700M
Total stockholder equity 3.67M 16.60M 4.39M 0.38M 0.18M
Deferred long term liab - - - - -
Other current liab 0.37M 0.16M 0.11M 0.00516M -
Common stock 0.02M 0.02M 0.01M 0.00689M 0.00596M
Capital stock 0.02M 0.02M 0.01M 0.00689M 0.00596M
Retained earnings -50.59767M -35.37465M -7.27440M -0.98520M -0.05973M
Other liab - - - - -
Good will 0.94M 0.94M 0.94M - -
Other assets - - - - -
Cash 1.93M 11.75M 4.26M 0.53M 0.16M
Cash and equivalents - - - - -
Total current liabilities 4.51M 1.57M 2.13M 0.34M 0.00700M
Current deferred revenue - - - - -
Net debt 0.80M -10.89295M -2.93095M -0.18032M -0.16132M
Short term debt 2.21M 0.17M 1.32M 0.32M -
Short long term debt 2.05M 0.05M 1.30M 0.30M -
Short long term debt total 2.73M 0.86M 1.33M 0.35M -
Other stockholder equity 54.24M 51.95M 11.66M 2.34M 0.30M
Property plant equipment - 0.91M 0.04M - -
Total current assets 6.75M 16.28M 4.99M 0.75M 0.19M
Long term investments - - - - -
Net tangible assets - 14.92M 2.89M 0.38M 0.18M
Short term investments 2.92M 2.91M - - -
Net receivables 0.65M 0.70M 0.26M 0.00231M 0.03M
Long term debt - - - - -
Inventory 0.44M 0.30M 0.23M 0.14M 0.00000M
Accounts payable 1.93M 1.24M 0.69M 0.01M 0.00700M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -0.98520M -0.05973M
Additional paid in capital - - - - -
Common stock total equity - - 0.01M 0.00689M 0.00596M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.38M - - -
Deferred long term asset charges - - - - -
Non current assets total 1.94M 2.59M 1.54M 0.00000M 0.00000M
Capital lease obligations 0.68M 0.81M 0.03M 0.05M 0.00000M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -2.47199M -13.14660M -0.24599M - -
Change to liabilities - 0.55M 0.00079M 0.00372M 0.04M
Total cashflows from investing activities - -13.14660M -0.24599M -0.24599M -0.24599M
Net borrowings - -0.18250M 0.36M 0.30M 0.30M
Total cash from financing activities -0.95556M 28.21M 6.71M 1.06M 1.46M
Change to operating activities - -0.32548M 1.05M 0.00849M -0.18000M
Net income -15.22303M -28.10025M -6.28920M -0.92546M -0.35840M
Change in cash -9.82349M 7.49M 3.73M 0.37M 0.97M
Begin period cash flow 11.75M 4.26M 0.53M 0.16M -
End period cash flow 1.93M 11.75M 4.26M 0.53M 0.16M
Total cash from operating activities -6.39594M -7.56764M -2.73274M -0.69274M -0.49640M
Issuance of capital stock 0.00000M 28.32M 5.86M 0.76M -
Depreciation 0.52M 0.19M 0.16M 0.16M 0.11M
Other cashflows from investing activities - -2.90830M -2.90830M -2.90830M -2.90830M
Dividends paid - - - - -
Change to inventory -0.13714M -0.07834M 0.04M -0.13548M -0.13548M
Change to account receivables 0.05M -0.40140M -0.09611M -0.00191M -0.00191M
Sale purchase of stock -2.88004M - - - -
Other cashflows from financing activities 1.84M 3.04M 1.65M 0.33M -0.02300M
Change to netincome - 18.99M 2.40M 0.36M 0.36M
Capital expenditures 0.01M 0.24M 0.04M 0.04M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.57M -0.25113M -0.04336M -0.12518M -
Stock based compensation 3.24M 9.39M 2.40M 0.36M -
Other non cash items 4.49M 1.60M 1.04M 0.33M -
Free cash flow -6.41093M -7.80594M -2.77674M -0.69274M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
JUPW
Jupiter Wellness Inc
- -% - - - 3.04 2.54 2.62 -0.8049
ZTS
Zoetis Inc
5.84 3.25% 185.50 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.06 0.18% 33.64 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-1.18 0.73% 160.95 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
0.14 0.99% 13.71 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Jupiter Wellness Inc

1061 East Indiantown Road, Jupiter, FL, United States, 33477

Key Executives

Name Title Year Born
Dr. Glynn Wilson Ph.D. Chief Science Officer & Chairman 1947
Mr. Brian Scott John Chief Investment Officer, CEO & Exec. Director 1969
Mr. Richard A. Miller Sec. & Director 1968
Mr. Douglas O. McKinnon Chief Financial Officer 1951
Dr. Andy Goren M.D. Chief Medical Officer & Member of Scientific Advisory Board 1972

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.